Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 73.62 USD 0.38% Market Closed
Market Cap: 8.7B USD

Henry Schein Inc
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Henry Schein Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Henry Schein Inc
NASDAQ:HSIC
Net Issuance of Debt
$431m
CAGR 3-Years
19%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Cardinal Health Inc
NYSE:CAH
Net Issuance of Debt
$3.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
10%
Adapthealth Corp
NASDAQ:AHCO
Net Issuance of Debt
-$288.8m
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Net Issuance of Debt
-$33.1m
CAGR 3-Years
23%
CAGR 5-Years
20%
CAGR 10-Years
13%
Mckesson Corp
NYSE:MCK
Net Issuance of Debt
$2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cencora Inc
NYSE:COR
Net Issuance of Debt
$3.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
8%
No Stocks Found

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HSIC Intrinsic Value
106.16 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Henry Schein Inc's Net Issuance of Debt?
Net Issuance of Debt
431m USD

Based on the financial report for Sep 27, 2025, Henry Schein Inc's Net Issuance of Debt amounts to 431m USD.

What is Henry Schein Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
61%

Over the last year, the Net Issuance of Debt growth was -43%. The average annual Net Issuance of Debt growth rates for Henry Schein Inc have been 19% over the past three years , 61% over the past five years .

Back to Top